Inspiratory Muscle Strength Training in Adults With Obesity
Launched by FLORIDA STATE UNIVERSITY · Jul 13, 2022
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a specific type of exercise called inspiratory muscle strength training can help lower blood pressure in adults who are obese. The goal is to find out if this training, which focuses on strengthening the muscles used for breathing, can lead to better health outcomes for individuals with obesity.
To participate in the study, individuals should have a body mass index (BMI) between 30 and 40, which indicates obesity. However, there are some conditions that may exclude someone from joining, such as having significant heart or lung problems, recent weight changes, or certain other health issues. Participants can expect to engage in breathing exercises and will be monitored throughout the trial. This study is currently recruiting participants of all genders between the ages of 18 and 65, and it aims to contribute valuable information about managing blood pressure in people with obesity.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Body mass index 30 - 40 kg/m2
- Exclusion Criteria:
- • Not weight stable (\<5% change in body mass over the past six months)
- • Overt cardiovascular, neurological, renal, liver, and/or metabolic illness (e.g., diabetes mellitus)
- • Current, or history of uncontrolled, Stage 2 hypertension (blood pressure \>140 / 90 mmHg; anti-hypertensive medications are permitted)
- • Diagnosed obstructive sleep apnea
- • Previous bariatric surgery
- • Diagnosis or signs (e.g., values below the lower limit of normal) of overt airway disease(s)
- • Current or recent (regular use within the past 6 months) use of tobacco or nicotine products (e.g., cigarettes, vaping)
- • Pregnant (self-reported and confirmed via urine pregnancy test), lactating (self-reported), or post-menopausal (self-reported) females
- • Prisoners
- * Per the POWERbreathe® company:
- • Patients who have undergone recent abdominal surgery and those with abdominal hernia.
- • Asthma patients who have a very low symptom perception and suffer from frequent, severe exacerbations or with an abnormally low perception of dyspnea.
- • If a patient is suffering from a ruptured eardrum or any other condition of the ear.
- • Patients with marked elevated left ventricular end-diastolic volume and pressure.
- • Patients with worsening heart failure signs and symptoms after training.
- • If an individual is suffering from a cold, sinusitis or respiratory tract infection, it is advised that they do not use the POWERbreathe device.
About Florida State University
Florida State University (FSU) is a prestigious public research institution located in Tallahassee, Florida, known for its commitment to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, FSU leverages its extensive academic resources and expertise to conduct rigorous research aimed at improving patient outcomes and contributing to the medical community. The university fosters a collaborative environment that brings together multidisciplinary teams to design, implement, and analyze clinical studies, ensuring adherence to the highest ethical and scientific standards. Through its clinical trials, FSU aims to address critical health challenges and translate research findings into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tallahassee, Florida, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials